South LA clinics offer preventive HIV medication
PrEP, an FDA-approved HIV medication when taken daily, is for people without HIV but are at high risk of contracting it
Charles R. Drew University / OASIS Clinic. Photo: drewu.edu/
Biomedical prevention services available at Charles R. Drew Oasis Clinic and Martin Luther King, Jr. Outpatient Center
LOS ANGELES — A biomedical deterrent to HIV (Human Immunodeficiency Virus), the precursor to AIDS, is now available to at-risk populations in South L.A., which suffers one of the highest HIV infection rates in the U.S.
The Oasis Clinic at Charles R. Drew University of Medicine and Science, and Martin Luther King, Jr. Outpatient Center are dispensing a pill called the Pre-exposure Prophylaxis (PrEP), one of the newest measures in HIV prevention.
PrEP, an FDA-approved HIV medication when taken daily, is for people who don’t have HIV but are at high risk of contracting it.
To support patient access to PrEP, known commercially as Truvada, CDC received a grant from Gilead Sciences, makers of the drug, to fund a program to assist patients in obtaining PrEP services.
“Many people who come to our HIV testing site have never heard about PrEP,” said CDC’s David P. Lee, director of the program. “That’s unfortunate because the need is greatest here in South Los Angeles. Hopefully, this is the beginning of complete access for this community.”
Services are available in English and Spanish. HIV testing and counseling are required. PrEP clinics are also available from 4-8 p.m. at Martin Luther King, Jr. Outpatient Center.
For more information call the Oasis Center at (323) 563-5804 or Martin Luther King, Jr. Center Outpatient Center at (323) 568-8100. Press “0” after the language prompt.
Information from cdrewu.edu contributed to this post